{"nct_id":"NCT02437890","title":"A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus","status":"COMPLETED","status_verified_date":"2019-02","start_date":"2015-07","start_date_type":null,"primary_completion_date":"2018-01","primary_completion_date_type":"ACTUAL","completion_date":"2018-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}